CATX
Price
$3.43
Change
+$0.27 (+8.54%)
Updated
Jan 17 closing price
Capitalization
751.25M
68 days until earnings call
PROF
Price
$7.35
Change
-$0.08 (-1.08%)
Updated
Jan 17 closing price
Capitalization
205.33M
52 days until earnings call
Ad is loading...

CATX vs PROF

Header iconCATX vs PROF Comparison
Open Charts CATX vs PROFBanner chart's image
Perspective Therapeutics
Price$3.43
Change+$0.27 (+8.54%)
Volume$1.12M
Capitalization751.25M
Profound Medical
Price$7.35
Change-$0.08 (-1.08%)
Volume$57.67K
Capitalization205.33M
CATX vs PROF Comparison Chart
Loading...
CATX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PROF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CATX vs. PROF commentary
Jan 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CATX is a Hold and PROF is a Hold.

Ad is loading...
COMPARISON
Comparison
Jan 19, 2025
Stock price -- (CATX: $3.43 vs. PROF: $7.35)
Brand notoriety: CATX and PROF are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: CATX: 57% vs. PROF: 71%
Market capitalization -- CATX: $751.25M vs. PROF: $205.33M
CATX [@Medical Specialties] is valued at $751.25M. PROF’s [@Medical Specialties] market capitalization is $205.33M. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.13B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CATX’s FA Score shows that 0 FA rating(s) are green whilePROF’s FA Score has 0 green FA rating(s).

  • CATX’s FA Score: 0 green, 5 red.
  • PROF’s FA Score: 0 green, 5 red.
According to our system of comparison, both CATX and PROF are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CATX’s TA Score shows that 3 TA indicator(s) are bullish while PROF’s TA Score has 3 bullish TA indicator(s).

  • CATX’s TA Score: 3 bullish, 5 bearish.
  • PROF’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, both CATX and PROF are a bad buy in the short-term.

Price Growth

CATX (@Medical Specialties) experienced а -2.00% price change this week, while PROF (@Medical Specialties) price change was -2.91% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +0.94%. For the same industry, the average monthly price growth was +5.49%, and the average quarterly price growth was +1.30%.

Reported Earning Dates

CATX is expected to report earnings on May 14, 2025.

PROF is expected to report earnings on May 12, 2025.

Industries' Descriptions

@Medical Specialties (+0.94% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CATX($751M) has a higher market cap than PROF($205M). CATX YTD gains are higher at: 7.524 vs. PROF (-2.130). PROF has higher annual earnings (EBITDA): -26.78M vs. CATX (-39.08M). PROF has more cash in the bank: 26.2M vs. CATX (9.24M). CATX has less debt than PROF: CATX (2.55M) vs PROF (7.94M). PROF has higher revenues than CATX: PROF (7.2M) vs CATX (0).
CATXPROFCATX / PROF
Capitalization751M205M366%
EBITDA-39.08M-26.78M146%
Gain YTD7.524-2.130-353%
P/E RatioN/AN/A-
Revenue07.2M-
Total Cash9.24M26.2M35%
Total Debt2.55M7.94M32%
FUNDAMENTALS RATINGS
CATX vs PROF: Fundamental Ratings
CATX
PROF
OUTLOOK RATING
1..100
145
VALUATION
overvalued / fair valued / undervalued
1..100
36
Fair valued
49
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9698
PRICE GROWTH RATING
1..100
6560
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
4450

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CATX's Valuation (36) in the Biotechnology industry is in the same range as PROF (49) in the null industry. This means that CATX’s stock grew similarly to PROF’s over the last 12 months.

CATX's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as PROF (100) in the null industry. This means that CATX’s stock grew similarly to PROF’s over the last 12 months.

CATX's SMR Rating (96) in the Biotechnology industry is in the same range as PROF (98) in the null industry. This means that CATX’s stock grew similarly to PROF’s over the last 12 months.

PROF's Price Growth Rating (60) in the null industry is in the same range as CATX (65) in the Biotechnology industry. This means that PROF’s stock grew similarly to CATX’s over the last 12 months.

PROF's P/E Growth Rating (100) in the null industry is in the same range as CATX (100) in the Biotechnology industry. This means that PROF’s stock grew similarly to CATX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CATXPROF
RSI
ODDS (%)
Bullish Trend 5 days ago
83%
N/A
Stochastic
ODDS (%)
Bearish Trend 5 days ago
88%
Bearish Trend 5 days ago
85%
Momentum
ODDS (%)
Bullish Trend 5 days ago
82%
Bullish Trend 5 days ago
78%
MACD
ODDS (%)
N/A
Bullish Trend 5 days ago
84%
TrendWeek
ODDS (%)
Bearish Trend 5 days ago
88%
Bearish Trend 5 days ago
83%
TrendMonth
ODDS (%)
Bearish Trend 5 days ago
89%
Bearish Trend 5 days ago
84%
Advances
ODDS (%)
Bullish Trend 12 days ago
79%
Bullish Trend 17 days ago
77%
Declines
ODDS (%)
Bearish Trend 5 days ago
87%
Bearish Trend 5 days ago
80%
BollingerBands
ODDS (%)
Bearish Trend 5 days ago
90%
Bearish Trend 5 days ago
77%
Aroon
ODDS (%)
Bearish Trend 5 days ago
90%
Bearish Trend 5 days ago
85%
View a ticker or compare two or three
Ad is loading...
CATX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PROF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
CRYPTO / NAMEPrice $Chg $Chg %
BTC.X104462.0400004705.133000
+4.72%
Bitcoin cryptocurrency
TSLA426.5012.68
+3.06%
Tesla
SPY597.585.94
+1.00%
SPDR® S&P 500® ETF Trust
AAPL229.981.72
+0.75%
Apple
GME27.51-0.21
-0.76%
GameStop Corp

CATX and

Correlation & Price change

A.I.dvisor indicates that over the last year, CATX has been closely correlated with STRR. These tickers have moved in lockstep 92% of the time. This A.I.-generated data suggests there is a high statistical probability that if CATX jumps, then STRR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CATX
1D Price
Change %
CATX100%
+8.54%
STRR - CATX
92%
Closely correlated
+0.88%
RBOT - CATX
40%
Loosely correlated
+11.15%
BJDX - CATX
33%
Loosely correlated
-5.63%
PROF - CATX
25%
Poorly correlated
-1.08%
DHR - CATX
24%
Poorly correlated
-1.46%
More

PROF and

Correlation & Price change

A.I.dvisor tells us that PROF and ALC have been poorly correlated (+27% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that PROF and ALC's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PROF
1D Price
Change %
PROF100%
-1.08%
ALC - PROF
27%
Poorly correlated
+0.27%
CATX - PROF
25%
Poorly correlated
+8.54%
VCYT - PROF
25%
Poorly correlated
-1.27%
SMTI - PROF
25%
Poorly correlated
-0.21%
AZTA - PROF
25%
Poorly correlated
-0.70%
More